Drug Trial Radar · NCT05037929
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,334
Actual
Start
Oct 5, 2021
Primary completion
Feb 24, 2025
Study completion Jul 7, 2025
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in combination with standard of care chronic obstructive pulmonary disease (COPD) maintenance therapy in patients with COPD who are former or current smokers and have a history of frequent exacerbations.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
AstegolimabDrug
Participants will receive SC astegolimab Q2W or Q4W.
PlaceboDrug
Participants will receive SC placebo Q2W.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Moderate and Severe COPD Exacerbations Over the 52-Week Treatment PeriodTime frame: Baseline up to Week 52
Locations
193 sites in 24 countries. Site status is shown where the registry gives one.
SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS
Dothan, Alabama
Jasper Summit Research LLC
Jasper, Alabama
Pulmonary Associates of Mobile PC
Mobile, Alabama
Cadena Care Institute, LLC
Poway, California
Inst. of Healthcare Assessment, Inc.
San Diego, California
Allianz Research Institute Inc
Westminster, California
St. Francis Sleep
Clearwater, Florida
Clinical Site Partners - Leesburg Suite 101 - HyperCore - PPDS
Leesburg, Florida
Pulmonary Specialists of the Palm Beaches
Loxahatchee Groves, Florida
Florida Institute for Clinical Research, LLC
Orlando, Florida
Clinical Site Partners - Winter Park - HyperCore - PPDS
Winter Park, Florida
Northwestern Center for Clinical Research
Chicago, Illinois
Medisphere Medical Research Center, Llc
Evansville, Indiana
Exordia Medical Research, Inc.
Fall River, Massachusetts
Northern Pines Health Center PC
Buckley, Michigan
Revive Research Institute
Lathrup Village, Michigan
Oakland Medical Research
Troy, Michigan
Cardio-Pulmonary Associates
Chesterfield, Missouri
Blessing Health Hannibal
Hannibal, Missouri
Midwest Chest Consultants
Saint Charles, Missouri
CARE Clinical Research
St Louis, Missouri
Midwest Clinical Research LLC
St Louis, Missouri
Sierra Clinical Research - ClinEdge - PPDS
Las Vegas, Nevada
American Health Research Inc.
Charlotte, North Carolina
Clinical Research of Gastonia
Gastonia, North Carolina
Carolina Research Center
Shelby, North Carolina
Southeastern Research Center
Winston-Salem, North Carolina
Temple University Hospital
Philadelphia, Pennsylvania
Lowcountry Lung and Critical Care
North Charleston, South Carolina
Clinical Research of Rock Hill
Rock Hill, South Carolina
Velocity Clinical Research Spartanburg PPDS
Spartanburg, South Carolina
South Texas Medical Research Institute, Inc., dba TTS Research ? ClinEdge ? PPDS
Boerne, Texas
Baylor College of Medicine
Houston, Texas
Metroplex Pulmonology & Sleep Center
McKinney, Texas
Sherman Clinical Research - ClinEdge - PPDS
Sherman, Texas
University of Virginia Health System
Charlottesville, Virginia
Centro de Investigaciones Clínicas Belgrano
Buenos Aires, Argentina
Instituto de Investigaciones Clinicas-Mar del Plata
Buenos Aires, Argentina
Fundacion Cidea
Buenos Aires, Argentina
Centro Médico Dra de Salvo
Buenos Aires, Argentina
Showing 40 of 193 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.